Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Ribas, Antoni, Prof, Puzanov, Igor, MD, Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Hamid, Omid, MD, Robert, Caroline, Prof, Hodi, F Stephen, MD, Schachter, Jacob, Prof, Pavlick, Anna C, MD, Lewis, Karl D, MD, Cranmer, Lee D, MD, Blank, Christian U, MD, O'Day, Steven J, MD, Ascierto, Paolo A, Prof, Salama, April K S, MD, Margolin, Kim A, Prof, Loquai, Carmen, MD, Eigentler, Thomas K, MD, Gangadhar, Tara C, MD, Carlino, Matteo S, MBBS, Agarwala, Sanjiv S, Prof, Moschos, Stergios J, MD, Sosman, Jeffrey A, Prof, Goldinger, Simone M, MD, Shapira-Frommer, Ronnie, MD, Gonzalez, Rene, Prof, Kirkwood, John M, Prof, Wolchok, Jedd D, Prof, Eggermont, Alexander, Prof, Li, Xiaoyun Nicole, PhD, Zhou, Wei, PhD, Zernhelt, Adriane M, BS, Lis, Joy, BSN, Ebbinghaus, Scot, MD, Kang, S Peter, MD, Daud, Adil, Prof
Published in The lancet oncology (01.08.2015)
Published in The lancet oncology (01.08.2015)
Get full text
Journal Article
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study
Cohen, Marc, Théroux, Pierre, Borzak, Steven, Frey, Martin J., White, Harvey D., Van Mieghem, W., Senatore, Fred, Lis, Joy, Mukherjee, Robin, Harris, Kathy, Bigonzi, Frederique
Published in The American heart journal (01.09.2002)
Published in The American heart journal (01.09.2002)
Get full text
Journal Article
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
Dummer, Reinhard, Daud, Adil, Puzanov, Igor, Hamid, Omid, Schadendorf, Dirk, Robert, Caroline, Schachter, Jacob, Pavlick, Anna, Gonzalez, Rene, Hodi, F, Cranmer, Lee D, Blank, Christian, O’Day, Steven J, Ascierto, Paolo A, Salama, April K S, Li, Nicole Xiaoyun, Zhou, Wei, Lis, Joy, Ebbinghaus, Scot, Kang, Peter S, Ribas, Antoni
Published in Journal of translational medicine (15.01.2015)
Published in Journal of translational medicine (15.01.2015)
Get full text
Journal Article
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and asoirin: The acute II study
COHEN, Marc, THEROUX, Pierre, BIGONZI, Frederique, BORZAK, Steven, FREY, Martin J, WHITE, Harvey D, VAN MIEGHEM, W, SENATORE, Fred, LIS, Joy, MUKHERIEE, Robin, HARRIS, Kathy
Published in The American heart journal (2002)
Get full text
Published in The American heart journal (2002)
Journal Article
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin
Cohen, Marc, Théroux, Pierre, Borzak, Steven, Frey, Martin J, White, Harvey D, Van Mieghem, W, Senatore, Fred, Lis, Joy, Mukherjee, Robin, Harris, Kathy, Bigonzi, Frederique
Published in The American heart journal (01.09.2002)
Get full text
Published in The American heart journal (01.09.2002)
Journal Article